Clinical value of early assessment of hyperfibrinolysis by rotational thromboelastometry during postpartum hemorrhage for the prediction of severity of bleeding: A multicenter prospective cohort study in the Netherlands

Marije Tahitu, Paul I Ramler, Ada Gillissen, Camila Caram-Deelder, Dacia D C A Henriquez, Moniek P M de Maat, Johannes J Duvekot, Jeroen Eikenboom, Kitty W M Bloemenkamp, Thomas van den Akker, Johanna G van der Bom, Marije Tahitu, Paul I Ramler, Ada Gillissen, Camila Caram-Deelder, Dacia D C A Henriquez, Moniek P M de Maat, Johannes J Duvekot, Jeroen Eikenboom, Kitty W M Bloemenkamp, Thomas van den Akker, Johanna G van der Bom

Abstract

Introduction: Coagulopathy may be the result of hyperfibrinolysis and could exacerbate bleeding following childbirth. Timely recognition of hyperfibrinolysis during the earliest stages of postpartum hemorrhage could identify women at risk of more severe blood loss who may benefit from targeted anti-fibrinolytic therapy. Rotational thromboelastometry (ROTEM® ) is a point-of-care test that could detect hyperfibrinolysis. The aim of this study was to evaluate whether early assessment of hyperfibrinolysis by ROTEM during postpartum hemorrhage could predict progression to severe postpartum hemorrhage.

Material and methods: During a prospective cohort study in the Netherlands among women with postpartum hemorrhage (total blood loss at least 1000 ml within 24 h after childbirth) ROTEM measurements were performed following 800-1500 ml of blood loss. Hyperfibrinolysis was defined as an enzymatic fibrinolysis index (ROTEM EXTEM maximum clot lysis [ML] minus the ROTEM APTEM ML) above 15%. Severe postpartum hemorrhage was defined as a composite end point of total blood loss greater than 2000 ml, transfusion of four or more units of packed cells, and/or need for an invasive intervention. The predictive value of hyperfibrinolysis for progression to severe postpartum hemorrhage was assessed by area under the receiver operating curve (AUC) and positive and negative predictive values.

Trial registration: ClinicalTrials.gov (NCT02149472).

Results: Of 390 women included, 82 (21%) had severe postpartum hemorrhage. Four (1%) women had thromboelastometric evidence of hyperfibrinolysis, of whom two developed severe postpartum hemorrhage. The AUC for enzymatic fibrinolysis index more than 15% for progression to severe postpartum hemorrhage was 0.47 (95% CI 0.40-0.54). Positive and negative predictive values for this index were 50.0% (95% CI 6.8-93.2) and 79.3% (95% CI 74.9-83.2), respectively.

Conclusions: Thromboelastometric evidence of hyperfibrinolysis was rare in women with postpartum hemorrhage when assessed between 800 and 1500 ml of blood loss. The clinical predictive value of viscoelastometric point-of-care testing for hyperfibrinolysis for progression to severe postpartum hemorrhage during early postpartum hemorrhage is limited.

Keywords: ROTEM®; hyperfibrinolysis; postpartum hemorrhage; rotational thromboelastometry; severity of bleeding.

Conflict of interest statement

None.

© 2021 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Figures

FIGURE 1
FIGURE 1
Flowchart of study enrollment

References

    1. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014;2:323‐333.
    1. Zwart JJ, Richters JM, Öry F, de Vries JIP, Bloemenkamp KWM, van Roosmalen J. Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population‐based study of 371 000 pregnancies. BJOG. 2008;115:842‐850.
    1. Oh KJ, Hong JS, Youm J, Cho SH, Jung EY. Can coagulopathy in post‐partum hemorrhage predict maternal morbidity? J Obstet Gynaecol Res. 2016;42:1509‐1518.
    1. Gall LS, Brohi K, Davenport RA. Diagnosis and treatment of hyperfibrinolysis in trauma (A European Perspective). Semin Thromb Hemost. 2017;43:224‐234.
    1. Kruithof EK, Tran‐Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood. 1987;69(2):460‐466.
    1. Shreeve NE, Barry JA, Deutsch LR, Gomez K, Kadir RA. Changes in thromboelastography parameters in pregnancy, labor, and the immediate postpartum period. Int J Gynaecol Obstet. 2016;134:290‐293.
    1. Royal College of Obstetricians and Gynaecologists (RCOG) . Immediate management of major postpartum haemorrhage (PPH). Accessed January 17, 2021.
    1. Dutch Society of Obstatrics and Gynaecology (NVOG) . Wat is de rol van Tranexaminezuur. “Role of tranexamic acid in postpartum haemorrhage”. 2019. Accessed April 7, 2020.
    1. World Health Organization (WHO) . WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. 2017. Accessed April 7, 2020.
    1. Kutcher ME, Cripps MW, McCreery RC, et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012;73:87‐93.
    1. Ramler PI, Gillissen A, Henriquez DDCA, et al. Clinical value of early viscoelastometric point‐of‐care testing during postpartum hemorrhage for the prediction of severity of bleeding: a multicenter prospective cohort study in the Netherlands. Acta Obstet Gynecol Scand. 2021;100:1656‐1664.
    1. Gillissen A, van den Akker T, Caram‐Deelder C, et al. Comparison of thromboelastometry by ROTEM® Delta and ROTEM® Sigma in women with postpartum haemorrhage. Scand J Clin Lab Invest. 2019;79:32‐38.
    1. Dutch Society of Obstatrics and Gynaecology (NVOG) . Hemorrhagia postpartum “Postpartum haemorrhage”. 2015. Accessed April 7, 2020.
    1. Mavrides E, Allard S, Chandraharan E, et al; On behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage: green‐top guideline No. 52. BJOG. 2017;124:106‐149.
    1. Kim JS, Wang IJ, Yeom SR, et al. Usefulness of rotational thromboelastometry as a mortality predictor of hyperfibrinolysis in patients with severe trauma. Acute Crit Care. 2018;33:162‐169.
    1. Lang T, Bauters A, Braun S, et al. Multi‐centre investigation on reference ranges for ROTEM. Blood Coagul Fibrinolysis. 2005;16:301‐310.
    1. Ilich A, Bokarev I, Key NS. Global assays of fibrinolysis. Int J Lab Hematol. 2017;39:441‐447.
    1. Schaap T, Bloemenkamp K, Deneux‐Tharaux C, et al. Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity. BJOG. 2019;126:394‐401.
    1. Meher S, Cuthbert A, Kirkham JJ, et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG. 2019;126:83‐93.
    1. de Lange NM, van Rheenen‐Flach LE, Lancé MD, et al. Peri‐partum reference ranges for ROTEM® thromboelastometry. Br J Anaesth. 2014;112:852‐859.
    1. Roberts I, Shakur H, Fawole B, et al. Haematological and fibrinolytic status of Nigerian women with post‐partum haemorrhage. BMC Pregnancy Childbirth. 2018;18:1‐8.
    1. Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post‐partum haemorrhage (WOMAN): an international, randomised, double‐blind, placebo‐controlled trial. Lancet. 2017;389:2105‐2116.
    1. Gillissen A, Henriquez DDCA, van den Akker T, et al. The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: a nationwide retrospective cohort study. PLoS One. 2017;12:e0187555.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera